title: Polo-like kinase 1 may regulate G2/M transition of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2.
abstract: Polo-like kinase 1(Plk1) has been reported to be a multifunctional kinase that plays pivotal regulatory roles in microtubule assembly during mammalian early embryonic mitosis. In the present study, we examined the expression of Plk1 at protein and mRNA level in mouse fertilized eggs by Western blot and RT-PCR. We also examined the kinase activity of Plk1. At various developmental phases of mouse one-cell stage embryos, both the protein and the mRNA of Plk1 were uniformly distributed; but the kinase activity of Plk1 increased at G2/M phase and decreased at the end of M phase. At the meantime, the phosphorylation of Tyr 15 of Cdc2 was inhibited at M phase. To investigate its function in mammalian fertilized eggs further, we used specific short hairpin RNAs (shRNA) and scytonemin, the putative inhibitor of Plk1 to suppress the activity of Plk1 in mouse fertilized eggs. Upon blockage of the activation of with Plk1 shRNA and scytonemin in mouse one-cell stage embryos, the cleavage rate decreased and the phosphorylation level of Tyr 15 of Cdc2 increased. These results imply that the Plk1 may regulate cell cycle progression of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2.
authors.affiliation: Department of Biochemical and Molecular Biology, China Medical University, Shenyang, Liaoning, China.
authors.forename: Zhe
authors.initials: Z
authors.lastname: Zhang
authors.forename: Wen-Hui
authors.initials: WH
authors.lastname: Su
authors.forename: Chen
authors.initials: C
authors.lastname: Feng
authors.forename: Da-Hai
authors.initials: DH
authors.lastname: Yu
authors.forename: Cheng
authors.initials: C
authors.lastname: Cui
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Xu
authors.forename: Bing-Zhi
authors.initials: BZ
authors.lastname: Yu
mesh_terms: D000818:Animals; D016203:CDC2 Protein Kinase / Q000378:metabolism*; D018797:Cell Cycle Proteins / Q000235:genetics / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D047108:Embryonic Development / Q000187:drug effects; D005260:Female; D016195:G2 Phase / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic; D007211:Indoles / Q000494:pharmacology; D008297:Male; D051379:Mice; D010636:Phenols / Q000494:pharmacology; D010766:Phosphorylation; D011247:Pregnancy; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology*; D034622:RNA Interference / Q000502:physiology; D014443:Tyrosine / Q000378:metabolism; D015053:Zygote / Q000166:cytology* / Q000201:enzymology / Q000378:metabolism; D000097869:Polo-Like Kinase 1
chemical_list: D016203:CDC2 Protein Kinase; D018797:Cell Cycle Proteins; D007211:Indoles; D010636:Phenols; D017346:Protein Serine-Threonine Kinases; D011505:Protein-Tyrosine Kinases; D011518:Proto-Oncogene Proteins; D014443:Tyrosine; D000097869:Polo-Like Kinase 1; C083368:scytonemin